Matches in Nanopublications for { ?s ?p "[MTHFR C677T [OR: 1.96, 95% CI: 1.06-3.61] and GCP II C1561T [OR: 2.09, 95% CI: 1.09-3.97] were found to be associated with risk for CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP622357.RABb83vwKElY4aCRWdyfz2zkw8Uw0TTNBUrGOjaLbMvbM130_assertion description "[MTHFR C677T [OR: 1.96, 95% CI: 1.06-3.61] and GCP II C1561T [OR: 2.09, 95% CI: 1.09-3.97] were found to be associated with risk for CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622357.RABb83vwKElY4aCRWdyfz2zkw8Uw0TTNBUrGOjaLbMvbM130_provenance.
- NP513634.RAsxC1AzLw1rNImuZxv4q3BLov9S-QAkQyetJRO30A_4E130_assertion description "[MTHFR C677T [OR: 1.96, 95% CI: 1.06-3.61] and GCP II C1561T [OR: 2.09, 95% CI: 1.09-3.97] were found to be associated with risk for CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513634.RAsxC1AzLw1rNImuZxv4q3BLov9S-QAkQyetJRO30A_4E130_provenance.
- NP637410.RAgkVV7MC75XToNXzX-50aWXevqRhuW2Z9KtDHAlHyeyk130_assertion description "[MTHFR C677T [OR: 1.96, 95% CI: 1.06-3.61] and GCP II C1561T [OR: 2.09, 95% CI: 1.09-3.97] were found to be associated with risk for CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637410.RAgkVV7MC75XToNXzX-50aWXevqRhuW2Z9KtDHAlHyeyk130_provenance.
- NP360288.RAIrUyoyLd9bALfrTQ0xtEbCmZaXEl3ltwlAJYs4oxaKo130_assertion description "[MTHFR C677T [OR: 1.96, 95% CI: 1.06-3.61] and GCP II C1561T [OR: 2.09, 95% CI: 1.09-3.97] were found to be associated with risk for CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360288.RAIrUyoyLd9bALfrTQ0xtEbCmZaXEl3ltwlAJYs4oxaKo130_provenance.
- assertion description "[MTHFR C677T [OR: 1.96, 95% CI: 1.06-3.61] and GCP II C1561T [OR: 2.09, 95% CI: 1.09-3.97] were found to be associated with risk for CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP382280.RAEqvPXiDoJ2thAvzdcAW35GKcEfyZGx4GmBnwyt4ZPgQ130_assertion description "[MTHFR C677T [OR: 1.96, 95% CI: 1.06-3.61] and GCP II C1561T [OR: 2.09, 95% CI: 1.09-3.97] were found to be associated with risk for CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382280.RAEqvPXiDoJ2thAvzdcAW35GKcEfyZGx4GmBnwyt4ZPgQ130_provenance.
- NP630589.RAKTzAfGdjhLQMHYgeeOBdeICvTwoP9RkeIxyD2TB2w1Q130_assertion description "[MTHFR C677T [OR: 1.96, 95% CI: 1.06-3.61] and GCP II C1561T [OR: 2.09, 95% CI: 1.09-3.97] were found to be associated with risk for CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630589.RAKTzAfGdjhLQMHYgeeOBdeICvTwoP9RkeIxyD2TB2w1Q130_provenance.
- assertion description "[MTHFR C677T [OR: 1.96, 95% CI: 1.06-3.61] and GCP II C1561T [OR: 2.09, 95% CI: 1.09-3.97] were found to be associated with risk for CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MTHFR C677T [OR: 1.96, 95% CI: 1.06-3.61] and GCP II C1561T [OR: 2.09, 95% CI: 1.09-3.97] were found to be associated with risk for CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP856717.RAF2fBJq4Fp_oiqW9ARJOloOueikF8nuTtJ3ZLxOgxtkA130_assertion description "[MTHFR C677T [OR: 1.96, 95% CI: 1.06-3.61] and GCP II C1561T [OR: 2.09, 95% CI: 1.09-3.97] were found to be associated with risk for CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856717.RAF2fBJq4Fp_oiqW9ARJOloOueikF8nuTtJ3ZLxOgxtkA130_provenance.